{"id":2866,"date":"2024-02-29T10:34:32","date_gmt":"2024-02-29T10:34:32","guid":{"rendered":"https:\/\/avaeh.org\/web_nueva_2021\/?p=2866"},"modified":"2024-02-29T10:35:26","modified_gmt":"2024-02-29T10:35:26","slug":"skyhawk-therapeutics-avanza-en-su-estudio-que-evalua-sky-0515-para-la-enfermedad-de-huntington","status":"publish","type":"post","link":"https:\/\/avaeh.org\/web_nueva_2021\/2024\/02\/29\/skyhawk-therapeutics-avanza-en-su-estudio-que-evalua-sky-0515-para-la-enfermedad-de-huntington\/","title":{"rendered":"Skyhawk Therapeutics avanza en su estudio que eval\u00faa SKY-0515 para la enfermedad de Huntington"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.europapress.es\/comunicados\/internacional-00907\/noticia-comunicado-skyhawk-therapeutics-avanza-estudio-evalua-sky-0515-enfermedad-huntington-20240228200733.html\" target=\"_blank\" rel=\"noreferrer noopener\">LINK ART\u00cdCULO COMPLETO<\/a><\/p>\n\n\n\n<p><strong>\u00abSkyhawk Therapeutics ha avanzado a la parte de dosis m\u00faltiples ascendentes de su estudio de fase 1 que eval\u00faa SKY-0515, una peque\u00f1a mol\u00e9cula dirigida a ARN para la enfermedad de\u00a0Huntington<\/strong>\u00ab<\/p>\n","protected":false},"excerpt":{"rendered":"<p>LINK ART\u00cdCULO COMPLETO \u00abSkyhawk Therapeutics ha avanzado a la parte de dosis m\u00faltiples ascendentes de su estudio de fase 1 que eval\u00faa SKY-0515, una peque\u00f1a mol\u00e9cula dirigida a ARN para la enfermedad de\u00a0Huntington\u00ab<\/p>\n","protected":false},"author":1,"featured_media":2734,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7,6,4,735,5,432,58,8,753,754],"class_list":["post-2866","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categoria","tag-asociacion-valenciana-de-enfermedad-de-huntington","tag-avaeh","tag-enfermedad-de-huntington","tag-estudio-huntington","tag-huntingtons-disease","tag-investigacion-huntington","tag-neurodegenerativa","tag-rare-diseases","tag-sky-0515","tag-skyhawk-therapeutics"],"_links":{"self":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/2866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/comments?post=2866"}],"version-history":[{"count":1,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/2866\/revisions"}],"predecessor-version":[{"id":2867,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/2866\/revisions\/2867"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/media\/2734"}],"wp:attachment":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/media?parent=2866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/categories?post=2866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/tags?post=2866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}